Products
Pharmaceutical-Grade Ingredients. Certified Supply.
Farmakem provides a certified selection of pharmaceutical-grade raw materials, active pharmaceutical ingredients (APIs), medicinal products, and food & cosmetic grade materials — all supplied under strict EU GMP and GDP compliance.
With over 178 authorized APIs and our own GMP-manufactured CBD API (Cebexan®), we ensure quality, safety, and regulatory reliability for every partner.
Raw Materials
We offer a wide range of pharmaceutical raw materials tailored to the specific needs of our B2B clients, available upon request:
Active Pharmaceutical Ingredients (APIs)
Narcotics
Semi-solid bases
Fatty oils
Essential oils
Medicinal herbs
Our current GDP license includes 178 approved APIs, all distributed upon customer request and in accordance with regulatory standards.
Medicinal Products
Farmakem is licensed for the wholesale distribution of finished medicinal products under GDP guidelines. While we do not list specific medications online, our offerings cover a wide portfolio tailored to partner needs.
Food and Cosmetic Grade Raw Materials
We also offer a broad range of food- and cosmetic-grade raw materials, ensuring safety and consistency across industries. Whether you’re formulating nutritional supplements or personal care products, Farmakem delivers the quality and flexibility you need.
Phytocannabinoid Cannabidiol (CBD)
Farmakem’s CBD raw materials adhere to strict European pharmacopoeia standards, ensuring consistent purity, quality, and regulatory compliance for pharmaceutical and clinical applications. Our cannabinoid products are sourced, processed, and handled under controlled GDP and GMP environments, enabling safe integration into extemporaneously prepared medicines, research formulations, and other therapeutic preparations.
Flagship Product
Cebexan® – Cannabidiol API (Ph.Eur)
Cebexan® – Cannabidiol API (Ph.Eur) is Farmakem’s proprietary cannabis product for pharmaceutical use in extemporaneously prepared medicines.
Plant-based & pharmaceutical grade cannabidiol (CBD) isolate compliant with Ph. Eur. monography 07/2024:3151.
Quality
Active pharmaceutical ingredient must comply with highest pharmacopeia standards (PhEur and DAC/NRF monographies should be followed).
Safety
Research has shown that safety profile of cannabidiol remained unchanged after 72 weeks in patients with Lennox- Gastaut syndrome and Dravet syndrom.
Efficiacy
Clinically proven in the treatment of rare and severe forms of epilepsy.
Get In Touch With Us
How Can We Assist You?
Share the details of your request and our team will respond promptly.
-
Mail us:
info@farmakem.si
-
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8:00 a.m. – 4:00 p.m.
-
Mail us:
info@farmakem.si
-
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8 a.m. – 4 p.m.
-
Mail us:
info@farmakem.si
-
Call us:
+386 262 007 91
Office Hours
Mon–Fri: 8 a.m. – 4 p.m.
